Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy

Clinical trial NCT00448097 · TERMINATED

Trial details

NCT number: NCT00448097
Sponsor: The Methodist Hospital Research Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2007-02-01
Primary completion: 2008-06-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.